142 related articles for article (PubMed ID: 29412177)
1. Medulloblastoma with myogenic and/or melanotic differentiation does not align immunohistochemically with the genetically defined molecular subgroups.
Gupta K; Jogunoori S; Satapathy A; Salunke P; Kumar N; Radotra BD; Vasishta RK
Hum Pathol; 2018 May; 75():26-33. PubMed ID: 29412177
[TBL] [Abstract][Full Text] [Related]
2. WNT-activated medulloblastoma with melanotic and myogenic differentiation: Report of a rare case.
Rajeshwari M; Kakkar A; Nalwa A; Suri V; Sarkar C; Satyarthee GD; Garg A; Sharma MC
Neuropathology; 2016 Aug; 36(4):372-5. PubMed ID: 26869281
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Accuracy of a Reduced Immunohistochemical Panel in Medulloblastoma Molecular Subtyping, Correlated to DNA-methylation Analysis.
Tauziède-Espariat A; Huybrechts S; Indersie E; Dufour C; Puget S; Chivet A; Roux A; Pagès M; Gareton A; Chrétien F; Lechapt E; Ayrault O; Varlet P
Am J Surg Pathol; 2021 Apr; 45(4):558-566. PubMed ID: 33323893
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Surrogates for Molecular Stratification in Medulloblastoma.
Chinnam D; Saraswati A; Jogunoori S; Verma A; Kiran T; Salunke P; Gupta N; Kumar N; Madan R; Radotra BD; Gupta K
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):561-568. PubMed ID: 37471625
[TBL] [Abstract][Full Text] [Related]
5. Clinicomorphological and molecular analysis of medulloblastoma and association with survival: A single tertiary care center experience.
Badiger S; Gudipati A; Uppin M; Konatam ML; Yeramneni VK; Bhattacharjee S; Saradhi MV; Patnaik S; Irukulla M
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S592-S602. PubMed ID: 38384024
[TBL] [Abstract][Full Text] [Related]
6. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
[TBL] [Abstract][Full Text] [Related]
7. Cerebellar medullomyoblastoma with melanotic tubular structures.
Nozza P; Milanaccio C; Piatelli G; Rossi A; Raso A; Cama A; Garré ML; Pietsch T
Pediatr Blood Cancer; 2008 Jan; 50(1):183-5. PubMed ID: 16550533
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
[TBL] [Abstract][Full Text] [Related]
9. Large cell/anaplastic medulloblastoma with myogenic, melanotic and neuronal differentiation: a case report of a rare tumor.
Fathaddin AA; Bakhash EA; Sabbagh AJ; Al-Dandan SW
Indian J Pathol Microbiol; 2014; 57(2):294-7. PubMed ID: 24943770
[TBL] [Abstract][Full Text] [Related]
10. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
[TBL] [Abstract][Full Text] [Related]
12. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
Ellison DW
Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
[TBL] [Abstract][Full Text] [Related]
13. Molecular Classification of Medulloblastoma.
Kijima N; Kanemura Y
Neurol Med Chir (Tokyo); 2016 Nov; 56(11):687-697. PubMed ID: 27238212
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma with focal divergent/teratoid differentiation.
Majumdar K; Tyagi I; Saran RK; Sakhuja P; Sharma A
Brain Tumor Pathol; 2013 Jan; 30(1):50-6. PubMed ID: 22615000
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups.
Eid AM; Heabah NAE
J Egypt Natl Canc Inst; 2021 Feb; 33(1):6. PubMed ID: 33555447
[TBL] [Abstract][Full Text] [Related]
16. Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups.
Chlapek P; Zitterbart K; Kren L; Filipova L; Sterba J; Veselska R
PLoS One; 2017; 12(2):e0172552. PubMed ID: 28231263
[TBL] [Abstract][Full Text] [Related]
17. Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline.
Pietsch T; Haberler C
Clin Neuropathol; 2016; 35(6):344-352. PubMed ID: 27781424
[TBL] [Abstract][Full Text] [Related]
18. Sonic Hedgehog-Activated Large Cell/Anaplastic Medulloblastoma with Myogenic Differentiation.
Rao S; Uppar AM; Santosh V
World Neurosurg; 2020 Mar; 135():16-18. PubMed ID: 31809895
[TBL] [Abstract][Full Text] [Related]
19. Large cell medulloblastoma with myogenic and melanotic differentiation: a case report with molecular analysis.
Polydorides AD; Perry A; Edgar MA
J Neurooncol; 2008 Jun; 88(2):193-7. PubMed ID: 18317693
[TBL] [Abstract][Full Text] [Related]
20. [Medullomyoblastoma: a medulloblastoma with rhabdomyoblastic differentiation].
Gauchotte G; Baylac F; Marie B; Vignaud JM
Ann Pathol; 2010 Apr; 30(2):135-8. PubMed ID: 20451073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
